Humana (NYSE:HUM) is a prominent player in the healthcare industry, providing a range of health insurance products and services. The company is known for its Medicare plans and has a significant presence in the U.S. healthcare market. Humana competes with other major insurers like UnitedHealth Group and Anthem.
On December 18, 2025, Erin Wright from Morgan Stanley set a price target of $262 for Humana. At that time, the stock was trading at $260.28, indicating a modest potential increase of 0.66%. This price target reflects confidence in Humana's future performance, supported by recent developments.
The U.S. Defense Department's decision to award Humana a $7.3 billion contract underscores the company's strong position in the healthcare sector. This deal involves providing healthcare and administrative support services, highlighting Humana's ongoing partnership with the Pentagon. Such contracts reinforce the trust and reliance the U.S. government places in Humana.
Currently, Humana's stock price is $260.28, showing an increase of $2.12 or 0.82%. The stock has experienced fluctuations, with a low of $256.35 and a high of $266.08 during the trading day. Over the past year, Humana's stock has ranged from a high of $315.35 to a low of $206.87.
Humana's market capitalization stands at approximately $31.3 billion, reflecting its significant presence in the healthcare industry. The trading volume for Humana today is 1,073,203 shares, indicating active investor interest. These metrics highlight the company's stability and potential for growth in the competitive healthcare market.
